Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 7
• 1.2 List of Figures 11

2 Introduction 13

• 2.1 Topical Absorbable Hemostats Overview 13

3 Products under Development 14

• 3.1 Topical Absorbable Hemostats - Pipeline Products by Stage of Development 14
• 3.2 Topical Absorbable Hemostats - Pipeline Products by Segment 15
• 3.3 Topical Absorbable Hemostats - Pipeline Products by Territory 16
• 3.4 Topical Absorbable Hemostats - Pipeline Products by Regulatory Path 17
• 3.5 Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date 18
• 3.6 Topical Absorbable Hemostats - Ongoing Clinical Trials 19

4 Topical Absorbable Hemostats - Pipeline Products under Development by Companies 20

• 4.1 Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development 20
• 4.2 Topical Absorbable Hemostats - Pipeline Products by Stage of Development 22

5 Topical Absorbable Hemostats Companies and Product Overview 24

• 5.1 3-D Matrix Ltd Company Overview 24
• 5.2 Angiotech Pharmaceuticals Inc Company Overview 30
• 5.3 Anika Therapeutics Inc Company Overview 31
• 5.4 APRUS Bio-Medical Innovations Pvt Ltd Company Overview 32
• 5.5 Arch Therapeutics Inc Company Overview 33
• 5.6 Baxter Healthcare Corp Company Overview 38
• 5.7 Baxter International Inc Company Overview 39
• 5.8 Beth Israel Deaconess Medical Center Inc Company Overview 52
• 5.9 Biomedica Management Corp Company Overview 53
• 5.10 Biom'Up SAS Company Overview 56
• 5.11 C. R. Bard Inc Company Overview 57
• 5.12 Cellphire Inc Company Overview 59
• 5.13 Ceramicos Para Aplicacoes Medicas SA Company Overview 63
• 5.14 Columbia University Company Overview 64
• 5.15 Covalent Medical, Inc. (Inactive) Company Overview 65
• 5.16 Covalon Technologies Ltd Company Overview 66
• 5.17 Cresilon Inc Company Overview 68
• 5.18 CryoLife Inc Company Overview 70
• 5.19 Endomedix Incorporated Company Overview 71
• 5.20 Entegrion Inc Company Overview 73
• 5.21 Ethicon US LLC Company Overview 74
• 5.22 ETX Pharma Inc Company Overview 76
• 5.23 Gamma Therapeutics Inc Company Overview 77
• 5.24 GATT Technologies BV Company Overview 78
• 5.25 gel-e Inc Company Overview 80
• 5.26 Haemostatix Ltd Company Overview 82
• 5.27 Hemostasis LLC Company Overview 84
• 5.28 HLL Lifecare Ltd Company Overview 86
• 5.29 Keratin Biosciences Inc Company Overview 87
• 5.30 Leader Biomedical Europe BV Company Overview 88
• 5.31 LifeBond Ltd Company Overview 89
• 5.32 Protege Biomedical Company Overview 90
• 5.33 Resorba GmbH Company Overview 91
• 5.34 Rice University Company Overview 93
• 5.35 Sanara MedTech Inc Company Overview 94
• 5.36 Sanofi Biosurgery Inc Company Overview 95
• 5.37 Sea Run Holdings Inc Company Overview 97
• 5.38 St Teresa Medical Inc Company Overview 98
• 5.39 Tectum Company Overview 100
• 5.40 The Medicines Company Company Overview 102
• 5.41 Therus Corporation Company Overview 103
• 5.42 Thrombotargets Corp Company Overview 104
• 5.43 United Health Products, Inc. Company Overview 108
• 5.44 University of Grenoble Alpes Company Overview 111
• 5.45 Virginia Commonwealth University Company Overview 112
• 5.46 Xcede Technologies Inc Company Overview 113

6 Topical Absorbable Hemostats- Recent Developments 116

• 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 116
• 6.2 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 118
• 6.3 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 119
• 6.4 Oct 31, 2019: gel-e announces breakthrough status designation from the U.S. Food and Drug Administration (FDA) for its first internal-use flowable device 119
• 6.5 Oct 31, 2019: Sanofi Q3 well on track 120
• 6.6 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran 123
• 6.7 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 125
• 6.8 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 126
• 6.9 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 129
• 6.10 Oct 24, 2019: Anika reports third quarter 2019 financial results 131

7 Appendix 293

• 7.1 Methodology 293
• 7.2 About GlobalData 296
• 7.3 Contact Us 296